'Standalone
net sales (including other operating income) of Gujarat Themis Biosyn has
increased 52.27% to Rs 42.01 crore.
Operating profit margin has declined from 52.05% to 49.80%, leading to
45.68% rise in operating profit to Rs 20.92 crore. Raw material cost as a % of total sales (net
of stock adjustments) decreased from 21.37% to 15.39%. Employee cost increased from 6.51% to
7.47%. Other expenses fell from 28.00%
to 24.69%. Stores consumed for sales
rose from 2.33% to 4.51%. Power and Oil
fuel cost fell from 19.96% to 15.94%.
Other
income fell 47.96% to Rs 1.02 crore.
PBIDT rose 34.44% to Rs 21.94 crore.
Provision for interest up 250% to Rs 0.07 crore. Loan funds rose to Rs 2.77 c...
Pleaselogin & subscribe to view the full report.
More Reports
-
(15-Jan-2026)
Swaraj Engines
OP surged 39.94%
-
(15-Jan-2026)
Indian Overseas Bank
Strong loan growth, margins improve
-
(15-Jan-2026)
Infosys
Revenue up 9% YoY to Rs 45479 crore in Q3FY2026
-
(15-Jan-2026)
Tata Elxsi
Revenue up 1.5% yoy to Rs 953.5 crore in Q3FY2026
|
|